Manufacturer

Janssen Pharmaceuticals, Inc.

Country

BELGIUM

Certificates

FDA

Document

0.35 MB

Registration Date	28 Jan 2015
Share

INVEGA ® SUSTENNA ®

star_borderstar_borderstar_borderstar_borderstar_border

(0)

Medicine Pharmaceuticals Product Number : 50458-560-01

Schizophrenia Drug

Drug Information

Generic

paliperidone palmitate

NDC Code

50458-560-01

Drug Class

Atypical antipsychotics

Therapeutic Class

Antipsychotic

Dosage form

Solution

Route of Administration

Intravenous Injection

Therapeutic Area

1.Schizophrenia

Indication

For the treatment of schizophrenia •Schizophrenia •Schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers or antidepressants

Benefit

INVEGA SUSTENNA® treats schizophrenia and schizoaffective disorder with one dose a month.* (INVEGA® SUSTENNA® is gradually released to control symptoms and reduce the chances of symptoms coming back when given monthly. That means you can have one less pill to take every day for treating schizophrenia—and know that your medication is in your system)